By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Madison Williams and Co., has started coverage of the life sciences tools industry, providing initial analysis on Bruker, Caliper Life Sciences, WaferGen BioSystems, and Waters.

Overall, analyst Greg Bolan said in a report that he is "bullish toward the secular theme of growing use of life sciences technologies and we feel the very recent contraction in [life science] valuations has created significant buying opportunities for several stocks."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.